Event Brief
Jan 14, 2026 at 6:02 AM ET
Amgen CEO Discusses Weight Loss Drug's Impact
By The BriefBrief
Bob Bradway highlights how Amgen's drug can improve patient adherence.
WHO: Bob Bradway
WHAT: Discussed weight loss drug
WHEN: Jan 12, 2026 at 7:00 PM ET
WHERE: CNBC Interview
WHY: To address patient persistence issue
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21434 of 21434
Same format. Every time.
Continue reading — sign in or create a free account with
